Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Uses of dopamine beta-hydroxylase (DBH) inhibitors and serotonin receptor (5-HT) antagonists for the treatment of cancer

Uses of dopamine beta-hydroxylase (DBH) inhibitors and serotonin receptor (5-HT) antagonists for the treatment of cancer

US Patent 11185542 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nitroxoline derivative, preparation method therefor, and use thereof2025
VR glasses2025
Non-isolated LLC resonant converter2025
Calibration of imaging system with combined optical coherence tomography and vis2025
Method for determining load-bearing deformation of solid waste materials and sys2025
Connector, connector assembly, and electronic device2025
Wall lamp2025
JAK kinase inhibitor, preparation method for same, and applications thereof in f2025
Ranging method, radar, and vehicle-mounted radar2025
Shutdown maintenance method and apparatus for wind turbine, and device following2025
Data processing method for neural network accelerator, device and storage medium2025
Beat frequency signal processing method and apparatus2025